Landscape Capital Management, L.L.C. Agenus Inc Transaction History

Landscape Capital Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$2.35 - $3.47 $112,800 - $166,560	-48,000 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$2.92 - $5.74 $140,160 - $275,520	48,000 New	48,000 $155,000
Q3 2018 Nov 14, 2018	SELL	$1.59 - $2.42 $28,400 - $43,226	-17,862 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.26 - $4.65 $40,368 - $83,058	17,862 New	17,862 $41,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.